Large-scale testing (Phase 3)Ended earlyNCT00897377What this trial is testingTreatment Strategy for Low-grade GliomasWho this might be right forAstrocytomasOligodendrogliomasOligoastrocytoma Sun Yat-sen University 500
Not applicableStudy completedNCT00213876What this trial is testingResearch of Molecular and Metabolic Markers in Oligodendrogliomas Comparatively to Other Brain TumoursWho this might be right forOligodendrogliomas University Hospital, Strasbourg, France 189
Not applicableStudy completedNCT00255671What this trial is testingAcute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain DisordersWho this might be right forBrain and Central Nervous System TumorsMetastatic CancerRadiation Toxicity Case Comprehensive Cancer Center 76
Early research (Phase 1)Study completedNCT00002753What this trial is testingMonoclonal Antibody Therapy in Treating Patients With Recurrent GliomasWho this might be right forBrain and Central Nervous System Tumors Duke University 6
Not applicableStudy completedNCT01417507What this trial is testingNatural History of Brain Function, Quality of Life, and Seizure Control in Patients With Brain Tumor Who Have Undergone SurgeryWho this might be right forAdult Diffuse AstrocytomaAdult Mixed GliomaAdult Oligodendroglioma+4 more Radiation Therapy Oncology Group 82
Early research (Phase 1)Ended earlyNCT01103375What this trial is testingErlotinib Hydrochloride and Isotretinoin in Treating Patients With Recurrent Malignant GliomaWho this might be right forAdult Anaplastic AstrocytomaAdult Anaplastic OligodendrogliomaAdult Diffuse Astrocytoma+6 more Wake Forest University Health Sciences 5
Testing effectiveness (Phase 2)Looking for participantsNCT07462507What this trial is testingInflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1Who this might be right forCentral Nervous System CancerBrain Metastases Washington University School of Medicine 104
Large-scale testing (Phase 3)Looking for participantsNCT04702581What this trial is testingTrial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than SurgeryWho this might be right forOligodendrogliomaLow-grade Oligodendroglioma1p19q Codeletion Hospices Civils de Lyon 280
Testing effectiveness (Phase 2)Ended earlyNCT01721577What this trial is testingPhase I/II Trial of AXL1717 in the Treatment of Recurrent Malignant AstrocytomasWho this might be right forGlioblastomaGliosarcomaAnaplastic Astrocytoma+3 more Rush University Medical Center 10
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07832123What this trial is testingSafusidenib for Patients With Newly Diagnosed IDH1-mutant CNS WHO Grade 3 Oligodendroglioma and Astrocytoma - a Single Arm Phase II StudyWho this might be right forGlioma : Oligodendroglioma or Astrocytoma University of Zurich 20
Large-scale testing (Phase 3)Active Not RecruitingNCT00887146What this trial is testingRadiation Therapy With Concomitant and Adjuvant Temozolomide Versus Radiation Therapy With Adjuvant PCV Chemotherapy in Patients With Anaplastic Glioma or Low Grade GliomaWho this might be right forBrain and Central Nervous System Tumors Alliance for Clinical Trials in Oncology 305
Testing effectiveness (Phase 2)Study completedNCT00301873What this trial is testingZoledronate in Preventing Osteoporosis in Patients With Primary Malignant GliomaWho this might be right forBrain TumorsOsteoporosisCentral Nervous System(CNS)Malignancies Duke University 60
Early research (Phase 1)Study completedNCT00509431What this trial is testingErlotinib and Sirolimus in Treating Patients With Recurrent Malignant GliomaWho this might be right forBrain and Central Nervous System Tumors Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT00036894What this trial is testingCC-5013 in Treating Patients With Recurrent GliomaWho this might be right forBrain and Central Nervous System Tumors National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00165360What this trial is testingProlonged Daily Temozolomide for Low-Grade GliomaWho this might be right forGliomaAstrocytomaOligodendroglioma Dana-Farber Cancer Institute 46
Not applicableStudy completedNCT00253669What this trial is testingRisk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed GliomasWho this might be right forBrain and Central Nervous System TumorsThromboembolism Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 110
Testing effectiveness (Phase 2)Study completedNCT00070161What this trial is testingPhase II Studies Of Donepezil And Ginkgo Biloba In Irradiated Brain TumorWho this might be right forBrain and Central Nervous System TumorsRadiation Toxicity Wake Forest University Health Sciences 68
Testing effectiveness (Phase 2)Study completedNCT00679354What this trial is testingCilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard TherapyWho this might be right forChildhood High-grade Cerebellar AstrocytomaChildhood High-grade Cerebral AstrocytomaRecurrent Childhood Anaplastic Astrocytoma+7 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT04908176What this trial is testingA Drug-drug Interaction Study of Avapritinib and MidazolamWho this might be right forGastrointestinal Stromal TumorsGISTNon-resectable Advanced Solid Tumors+1 more Blueprint Medicines Corporation 10
Early research (Phase 1)Study completedNCT02871843What this trial is testingRRx-001 + Radiation + Temozolomide In Newly Diagnosed Glioblastoma and Anaplastic GliomasWho this might be right forGlioblastomaOligodendrogliomaAnaplastic Oligodendroglioma EpicentRx, Inc. 19